On this episode of Ropes & Gray’s Antitrust Insights podcast series, strategic transactions partner Hannah England is joined by antitrust partners Jackie Grise and Zak Goodwin to discuss the practical implications of the new Hart–Scott–Rodino (“HSR”) Act rules, which go into effect on February 10, 2025, and the challenges faced by pharmaceutical clients and the strategic adjustments required for compliance. Tune in to understand how these changes will affect acquisitions, licensing and collaboration transactions and other strategic transactions, as well as the overall regulatory landscape.
